Therapeutic strategies targeting mitochondrial OS, known as mitochondrial-targeted antioxidants (MTAs) such as MitoQ, are modulators and promoters of mitochondrial biogenesis (PGC-1 activators), which have shown promise in preclinical HTN models (Halling et al., 2019)
This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos
A.GojiA
This clean-label herbal metabolic supplement promotes appetite contr
Tell your GP what you took, the dose, and any symptoms
S2CID 1310940